ArticlePhysics and imaging in radiation oncology2025
Implementation and clinical evaluation of an in-house thoracic auto-segmentation model for 0.35 T magnetic resonance imaging guided radiotherapy.
Article in Physics and imaging in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Direct integration of deep learning-based GTV auto-segmentation into a clinical radiotherapy planning system.Physics and imaging in radiation oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Purpose: Magnetic resonance imaging-guided radiotherapy (MRgRT) facilitates high accuracy, small margins treatments at the cost of time-consuming and labor-intensive manual delineation of organs-at-risk (OARs). Auto-segmentation models show promise in streamlining this workflow. This study investigates the clinical applicability of a set of thoracic OAR segmentation models for baseline treatment planning in lung tumor patients. We investigate the use of the models for treatment at a 0.35 T MR-linac, assess their potential to reduce physician workload in terms of time savings and quantify the extent of required manual corrections, providing insights into the value of their integration into clinical practice. Materials and Methods: Deep-learning based auto-segmentation models for 9 thoracic OARs were integrated into the MRgRT workflow. Two groups of 11 lung cancer cases each were prospectively considered. For Group 1 auto-segmentation contours were corrected by physicians, for Group 2 manual contouring according to standard clinical workflows was performed. Contouring times were recorded for both. Time savings between the groups as well as correlations of the extent of corrections to correction times for Group 1 patients were analyzed. Results: The model performed consistently well across all Group 1 cases. Median contouring times were reduced for six out of nine OARs leading to a reduction of 50.3 % or 12.6 min in median total contouring time. Conclusion: Feasibility of auto-segmentation for baseline treatment planning at the 0.35 T MR-linac was shown with significant time savings demonstrated. Time saving potential could not be estimated from model geometric performance metrics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.